Skip to main content
SpringerLink
Log in

Corticosteroid Therapy

  • Chapter
Pediatric Inflammatory Bowel Disease

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 179.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Markowitz J, Grancher K, Kohn N, Lesser M, Daum F. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn disease. Gastroenterology 2000;119(4):895–902.

    Article  PubMed  CAS  Google Scholar 

  2. Barnes PJ, Adcock IM. How do corticosteroids work in asthma? Ann Intern Med 2003;139(5 Pt 1): 359–70.

    Google Scholar 

  3. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids–new mechanisms for old drugs. N Engl J Med 2005;353(16):1711–23.

    Article  PubMed  CAS  Google Scholar 

  4. Heuschkel RB, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn disease in children. J Pediatr Gastroenterol Nutr 2000;31(1):8–15.

    Article  Google Scholar 

  5. Beattie RM, Nicholls SW, Domizio P, Williams CB, Walker-Smith JA. Endoscopic assessment of the colonic response to corticosteroids in children with ulcerative colitis. J Pediatr Gastroenterol Nutr 1996;22(4):373–9.

    Article  PubMed  CAS  Google Scholar 

  6. Travis SP, Stange EF, Lemann M, Oresland T, Chowers Y, Forbes A, et al. European evidence based consensus on the diagnosis and management of Crohn disease: current management. Gut 2006;55(Suppl 1):16–35.

    Article  Google Scholar 

  7. Markowitz J, Hyams J, Mack D, Leleiko N, Evans J, Kugathasan S, et al. Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn disease. Clin Gastroenterol Hepatol 2006;4(9):1124–9.

    Article  PubMed  CAS  Google Scholar 

  8. Hyams J, Markowitz J, Lerer T, Griffiths A, Mack D, Bousvaros A, et al. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol 2006;4(9):1118–23.

    Article  PubMed  CAS  Google Scholar 

  9. Faubion WA, Jr., Loftus EV, Jr., Harmsen WS, Zinsmeister AR, Sandborn WJ. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001;121(2):255–60.

    Article  PubMed  CAS  Google Scholar 

  10. Ho GT, Chiam P, Drummond H, Loane J, Arnott ID, Satsangi J. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther 2006;24(2):319–30.

    Article  PubMed  CAS  Google Scholar 

  11. Dilger K, Alberer M, Busch A, Enninger A, Behrens R, Koletzko S, et al. Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn disease. Aliment Pharmacol Ther 2006;23(3):387–96.

    Article  PubMed  CAS  Google Scholar 

  12. Lundin PD, Edsbacker S, Bergstrand M, Ejderhamn J, Linander H, Hogberg L, et al. Pharmacokinetics of budesonide controlled ileal release capsules in children and adults with active Crohn disease. Aliment Pharmacol Ther 2003;17(1):85–92.

    Article  PubMed  CAS  Google Scholar 

  13. Levine A, Weizman Z, Broide E, Shamir R, Shaoul R, Pacht A, et al. A comparison of budesonide and prednisone for the treatment of active pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2003;36(2):248–52.

    Article  PubMed  CAS  Google Scholar 

  14. Escher JC. Budesonide versus prednisolone for the treatment of active Crohn disease in children: a randomized, double-blind, controlled, multicentre trial. Eur J Gastroenterol Hepatol 2004;16(1):47–54.

    Article  PubMed  CAS  Google Scholar 

  15. Levine A, Broide E, Stein M, Bujanover Y, Weizman Z, Dinari G, et al. Evaluation of oral budesonide for treatment of mild and moderate exacerbations of Crohn disease in children. J Pediatr 2002;140(1):75–80.

    Article  PubMed  CAS  Google Scholar 

  16. Otley A, Steinhart AH. Budesonide for induction of remission in Crohn disease. Cochrane Database Syst Rev 2005(4):CD000296.

    Google Scholar 

  17. Rutgeerts P, Lofberg R, Malchow H, Lamers C, Olaison G, Jewell D, et al. A comparison of budesonide with prednisolone for active Crohn disease. N Engl J Med 1994;331(13):842–5.

    Article  PubMed  CAS  Google Scholar 

  18. Bar-Meir S, Chowers Y, Lavy A, Abramovitch D, Sternberg A, Leichtmann G, et al. Budesonide versus prednisone in the treatment of active Crohn disease. The Israeli Budesonide Study Group. Gastroenterology 1998;115(4):835–40.

    Article  PubMed  CAS  Google Scholar 

  19. Gross V, Andus T, Ecker KW, Raedler A, Loeschke K, Plauth M, et al. Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn disease. The Budesonide Study Group. Gut 1998;42(4):493–6.

    PubMed  CAS  Google Scholar 

  20. Campieri M, Ferguson A, Doe W, Persson T, Nilsson LG. Oral budesonide is as effective as oral prednisolone in active Crohn disease. The Global Budesonide Study Group. Gut 1997;41(2):209–14.

    Article  PubMed  CAS  Google Scholar 

  21. Levine A, Watemberg N, Hager H, Bujanover Y, Ballin A, Lerman-Sagie T. Benign intracranial hypertension associated with budesonide treatment in children with Crohn disease. J Child Neurol 2001;16(6):458–61.

    Article  PubMed  CAS  Google Scholar 

  22. Kundhal P, Zachos M, Holmes JL, Griffiths AM. Controlled ileal release budesonide in pediatric Crohn disease: efficacy and effect on growth. J Pediatr Gastroenterol Nutr 2001;33(1):75–80.

    Article  PubMed  CAS  Google Scholar 

  23. Greenberg GR, Feagan BG, Martin F, Sutherland LR, Thomson AB, Williams CN, et al. Oral budesonide as maintenance treatment for Crohn disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group. Gastroenterology 1996;110(1):45–51.

    Article  PubMed  CAS  Google Scholar 

  24. Lofberg R, Rutgeerts P, Malchow H, Lamers C, Danielsson A, Olaison G, et al. Budesonide prolongs time to relapse in ileal and ileocaecal Crohn disease. A placebo controlled one year study. Gut 1996;39(1):82–6.

    Article  PubMed  CAS  Google Scholar 

  25. Ferguson A, Campieri M, Doe W, Persson T, Nygard G. Oral budesonide as maintenance therapy in Crohn disease–results of a 12-month study. Global Budesonide Study Group. Aliment Pharmacol Ther 1998;12(2):175–83.

    Article  PubMed  CAS  Google Scholar 

  26. Simms L, Steinhart AH. Budesonide for maintenance of remission in Crohn disease. Cochrane Database Syst Rev 2001(1):CD002913.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Gastroenterology, Erasmus MC-Sophia Children’s Hospital, University Medical Center, Dr Molewaterplein 60, 3015 GJ Rotterdam, The Netherlands

    Johanna C. Escher

Authors
  1. Johanna C. Escher
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Attending Physician, Division of GI Hepatology and Nutrition, Director Endoscopy Suite, The Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

    Petar Mamula M.D. (Assistant Professor of Pediatrics) (Assistant Professor of Pediatrics)

  2. Attending Physician, Children’s Center for Digestive Health, Greenville Hospital System University Medical Center, University of South Carolina School of Medicine, Greenville, South Carolina, USA

    Jonathan E. Markowitz M.D., M.S.C.E. (Associate Professor of Clinical Pediatrics) (Associate Professor of Clinical Pediatrics)

  3. Attending Physician and Director, Inflammatory Bowel Disease Center Division of GI, Hepatology and Nutrition. The Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

    Robert N. Baldassano M.D. (Professor) (Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Escher, J.C. (2008). Corticosteroid Therapy. In: Mamula, P., Markowitz, J.E., Baldassano, R.N. (eds) Pediatric Inflammatory Bowel Disease. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-73481-1_28

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-73481-1_28

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-73480-4

  • Online ISBN: 978-0-387-73481-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation